Abstract
Aim: To compare the efficacy and safety of silodosin versus tamsulosin as medical expulsive therapy for stones of lower-third ureter in children. Patients and Methods: This prospective single-blind placebo-controlled randomized study included 167 pediatric patients who presented with distal ureteric stone (DUS) less than 1 cm. Patients were randomized into 3 groups; group I received silodosin 4 mg once daily, and group II received tamsulosin 0.4 mg while those in group III had placebo. The side effects of the used drugs, both rate and time of stone expulsion, and number of pain episodes were compared among the study groups for a maximum of 4 weeks. Results: Follow-up data of our patients after treatment revealed that the stone expulsion rate was significantly higher and the time to stone expulsion was significantly shorter in group I (89.3%, 12.4 ± 2.3 days) and group II (74.5%, 16.2 ± 4.2 days) compared to group III (51.8%, 21.2 ± 5.6). However, a statistically significant difference between silodosin and tamsulosin groups in favor of the former one was reported regarding the 2 studied items. Meanwhile, pain episodes requiring analgesia were statistically fewer in group I and II in contrast to placebo group. Adverse events were comparable among all groups. Conclusion: Silodosin provides significantly better stone expulsion rate and shorter expulsion time than tamsulosin for treatment of DUS. Both medications showed good safety profiles in children. However, further studies are required on a larger scale to confirm our results. Assessment of drug safety on younger age-group is still needed.
References
1.
Kroovand
RL
. Pediatric urolithiasis
. Urol Clin North Am
. 1997 Feb
;24
(1
):173
–84
. .2.
Pietropaolo
A
, Proietti
S
, Geraghty
R
, Skolarikos
A
, Papatsoris
A
, Liatsikos
E
, et al. Trends of ‘urolithiasis: interventions, simulation, and laser technology’ over the last 16 years (2000–2015) as published in the literature (PubMed): a systematic review from European section of Uro-technology (ESUT)
. World J Urol
. 2017 Nov
;35
(11
):1651
–8
. .3.
Fulgham
PF
, Assimos
DG
, Pearle
MS
, Preminger
GM
. Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessment
. J Urol
. 2013 Apr
;189
(4
):1203
–13
. .4.
Kupeli
B
, Irkilata
L
, Gurocak
S
, Tunc
L
, Kirac
M
, Karaoglan
U
, et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy?
Urology
. 2004 Dec
;64
(6
):1111
–5
.5.
Sasaki
S
, Tomiyama
Y
, Kobayashi
S
, Kojima
Y
, Kubota
Y
, Kohri
K
. Characterization of α1-adrenoceptor subtypes mediating contraction in human isolated ureters
. Urology
. 2011 Mar
;77
(3
):762
–7
. .6.
Turk
C
, Petrik
A
, Sarica
K
, Seitz
C
, Skolarikos
A
, Straub
M
, et al. EAU Guidelines on Interventional Treatment for Urolithiasis
. Eur Urol
. 2016 Mar
;69
(3
):475
–82
.7.
Parsons
JK
, Hergan
LA
, Sakamoto
K
, Lakin
C
. Efficacy of alpha-blockers for the treatment of ureteral stones
. J Urol
. 2007 Mar
;177
(3
):983
–7
; discussion 87
. .8.
Cohen
TD
, Ehreth
J
, King
LR
, Preminger
GM
. Pediatric urolithiasis: medical and surgical management
. Urology
. 1996 Mar
;47
(3
):292
–303
. .9.
Turk
C
, Petrik
A
, Sarica
K
, Seitz
C
, Skolarikos
A
, Straub
M
, et al. EAU Guidelines on diagnosis and conservative management of urolithiasis
. Eur Urol
. 2016 Mar
;69
(3
):468
–74
.10.
Sridharan
K
, Sivaramakrishnan
G
. Medical expulsive therapy in urolithiasis: a mixed treatment comparison network meta-analysis of randomized controlled clinical trials
. Expert Opin Pharmacother
. 2017 Oct
;18
(14
):1421
–31
. .11.
El-Galaly
H
, Sakr
A
, Fawzi
A
, Salem
EA
, Desoky
E
, Shahin
A
, et al. Silodosin vs tamsulosin in the management of distal ureteric stones: a prospective randomised study
. Arab J Urol
. 2016 Mar
;14
(1
):12
–7
. .12.
Sur
RL
, Shore
N
, L’Esperance
J
, Knudsen
B
, Gupta
M
, Olsen
S
, et al. Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trial
. Eur Urol
. 2015 May
;67
(5
):959
–64
. .13.
El-Galaly
H
, Eliwa
A
, Seleem
M
, Salem
E
, Omran
M
, Shello
H
, et al. Silodosin in the treatment of distal ureteric stones in children: a prospective, randomised, placebo-controlled study
. Arab J Urol
. 2017 Sep
;15
(3
):194
–8
. .14.
Huang
W
, Xue
P
, Zong
H
, Zhang
Y
. Efficacy and safety of silodosin in the medical expulsion therapy for distal ureteral calculi: a systematic review and meta-analysis
. Br J Clin Pharmacol
. 2016 Jan
;81
(1
):13
–22
. .15.
Ozsoy
M
, Liatsikos
E
, Scheffbuch
N
, Kallidonis
P
. Comparison of silodosin to tamsulosin for medical expulsive treatment of ureteral stones: a systematic review and meta-analysis
. Urolithiasis
. 2016 Nov
;44
(6
):491
–7
.16.
Yang
D
, Wu
J
, Yuan
H
, Cui
Y
. The efficacy and safety of silodosin for the treatment of ureteral stones: a systematic review and meta-analysis
. BMC Urol
. 2016 May 27
;16
(1
):23
. .17.
Liu
XJ
, Wen
JG
, Wan
YD
, Hu
BW
, Wang
QW
, Wang
Y
. Role of silodosin as medical expulsive therapy in ureteral calculi: a meta-analysis of randomized controlled trials
. Urolithiasis
. 2018 Apr
;46
(2
):211
–8
. .18.
Rahman
MJ
, Faridi
MS
, Mibang
N
, Singh
RS
. Comparing tamsulosin, silodosin versus silodosin plus tadalafil as medical expulsive therapy for lower ureteric stones: a randomised trial
. Arab J Urol
. 2018 Jun
;16
(2
):245
–9
. .19.
Ahmed
AF
, Al-Sayed
AY
. Tamsulosin versus alfuzosin in the treatment of patients with distal ureteral stones: prospective, randomized, comparative study
. Korean J Urol
. 2010 Mar
;51
(3
):193
–7
. .20.
Al-Ansari
A
, Al-Naimi
A
, Alobaidy
A
, Assadiq
K
, Azmi
MD
, Shokeir
AA
. Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients
. Urology
. 2010 Jan
;75
(1
):4
–7
. .21.
Lu
Z
, Dong
Z
, Ding
H
, Wang
H
, Ma
B
, Wang
Z
. Tamsulosin for ureteral stones: a systematic review and meta-analysis of a randomized controlled trial
. Urol Int
. 2012
;89
(1
):107
–15
. .22.
Cui
Y
, Chen
J
, Zeng
F
, Liu
P
, Hu
J
, Li
H
, et al. Tamsulosin as a medical expulsive therapy for ureteral stones: a systematic review and meta-analysis of randomized controlled trials
. J Urol
. 2019 May
;201
(5
):950
–5
. .23.
Cain
MP
, Wu
SD
, Austin
PF
, Herndon
CD
, Rink
RC
. Alpha blocker therapy for children with dysfunctional voiding and urinary retention
. J Urol
. 2003 Oct
;170
(4 Pt 2
):1514
–7
; discussion 16–7
. .24.
Donohoe
JM
, Combs
AJ
, Glassberg
KI
. Primary bladder neck dysfunction in children and adolescents II: results of treatment with alpha-adrenergic antagonists
. J Urol
. 2005 Jan
;173
(1
):212
–6
. .25.
Mokhless
I
, Zahran
AR
, Youssif
M
, Fahmy
A
. Tamsulosin for the management of distal ureteral stones in children: a prospective randomized study
. J Pediatr Urol
. 2012 Oct
;8
(5
):544
–8
. .26.
Aydogdu
O
, Burgu
B
, Gucuk
A
, Suer
E
, Soygur
T
. Effectiveness of doxazosin in treatment of distal ureteral stones in children
. J Urol
. 2009 Dec
;182
(6
):2880
–4
. .27.
Wang
CJ
, Tsai
PC
, Chang
CH
. Efficacy of silodosin in expulsive therapy for distal ureteral stones: a randomized double-blinded controlled trial
. Urol J
. 2016 Jun 28
;13
(3
):2666
–71
.28.
Preminger
GM
, Tiselius
HG
, Assimos
DG
, Alken
P
, Buck
C
, Gallucci
M
, et al. 2007 guideline for the management of ureteral calculi
. J Urol
. 2007 Dec
;178
(6
):2418
–34
. .29.
Gharib
T
, Mohey
A
, Fathi
A
, Alhefnawy
M
, Alazaby
H
, Eldakhakhny
A
. Comparative study between silodosin and tamsulosin in expectant therapy of distal ureteral stones
. Urol Int
. 2018
;101
(2
):161
–6
. .30.
Erturhan
S
, Bayrak
O
, Sarica
K
, Seckiner
I
, Baturu
M
, Sen
H
. Efficacy of medical expulsive treatment with doxazosin in pediatric patients
. Urology
. 2013 Mar
;81
(3
):640
–3
. .31.
Tasian
GE
, Cost
NG
, Granberg
CF
, Pulido
JE
, Rivera
M
, Schwen
Z
, et al. Tamsulosin and spontaneous passage of ureteral stones in children: a multi-institutional cohort study
. J Urol
. 2014 Aug
;192
(2
):506
–11
. .32.
Aldaqadossi
HA
, Shaker
H
, Saifelnasr
M
, Gaber
M
. Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children
. Arab J Urol
. 2015 Jun
;13
(2
):107
–11
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
